US EditionHow IQVIA's multi-agent AI 'dream team' aims to rewrite the clinical trial rulebook
Summary by Drug Discovery and Development
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
How IQVIA's multi-agent AI 'dream team' aims to rewrite the clinical trial rulebook
2025 was predicted to be the “year of the agent,” referring to the AI technology that can perform autonomous tasks on behalf of a user. And the trends are lining up. “I think agents are already here,” said Raja Shankar, IQVIA’s vice president, machine learning. With adoption gaining ground in retail, financial services, customer service,… The post Inside IQVIA’s quest to build a multi-agent AI ‘dream team’ to transform clinical trials appeared f…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
